{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:21:47Z","timestamp":1792182107251,"version":"4.4.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":72,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.lpm.2022.104126","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T02:56:52Z","timestamp":1652410612000},"page":"104126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4561-7616","authenticated-orcid":false,"given":"Rein","family":"Willemze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2022.104126_bib0001","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0002","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0003","series-title":"World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tissue (Revised 4th edition)","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.lpm.2022.104126_bib0004","series-title":"World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tissue (Revised 4th edition)","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.lpm.2022.104126_bib0005","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0006","series-title":"WHO Classification of Skin Tumours (4th edition)","author":"Elder","year":"2018"},{"key":"10.1016\/j.lpm.2022.104126_bib0007","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2022.104126_bib0008","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.path.2014.02.003","article-title":"Mycosis Fungoides Variants","volume":"7","author":"Martinez-Escala","year":"2014","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.lpm.2022.104126_bib0009","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archderm.138.2.191","article-title":"Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients","volume":"138","author":"van Doorn","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0010","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archderm.144.6.738","article-title":"Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma","volume":"144","author":"Gerami","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0011","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamadermatol.2016.1597","article-title":"Clinical staging and prognostic factors in folliculotropic mycosis fungoides","volume":"152","author":"van Santen","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0012","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jaad.2016.03.009","article-title":"New insights into folliculotropic mycosis fungoides (FMF): A single-center experience","volume":"75","author":"Hodak","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0013","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/bjd.15355","article-title":"Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group","volume":"177","author":"van Santen","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0014","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/modpathol.3880088","article-title":"Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study","volume":"13","author":"Haghighi","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0015","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archdermatol.2008.46","article-title":"Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of thr Cutaneous Lymphoma Histopathology Task Force Group of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"144","author":"Kempf","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0016","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000017929","article-title":"Granulomatous slack skin. Report of three patients with an updated review of the literature","volume":"196","author":"van Haselen","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.lpm.2022.104126_bib0017","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3389\/fonc.2019.01558","article-title":"An Update on Molecular Biology of Cutaneous T Cell Lymphoma","volume":"9","author":"Walia","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.lpm.2022.104126_bib0018","first-page":"256","article-title":"S\u00e9zary syndrome: old enigmas, new targets","volume":"14","author":"Nicolay","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.lpm.2022.104126_bib0019","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0020","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/bloodadvances.2018022608","article-title":"Single-cell heterogeneity in S\u00e9zary syndrome","volume":"2","author":"Buus","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.lpm.2022.104126_bib0021","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood-2012-10-460535","article-title":"Use of PLS3, Twist, CD158k\/KIR3DL2, and NKp46 gene expression combination for reliable Sezary syndrome diagnosis","volume":"121","author":"Miichel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0022","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jid.2016.01.038","article-title":"Evaluation of Immunophenotypic and Molecular Biomarkers for Sezary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients","volume":"136","author":"Boonk","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0023","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.semdp.2016.11.002","article-title":"A new molecular paradigm in mycosis fungoides and Sezary syndrome","volume":"34","author":"Elenitoba-Johnson","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0024","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jid.2016.04.027","article-title":"Sezary Syndrome: Translating Genetic Diversity into Personalized Medicine","volume":"136","author":"Chevret","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0025","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0026","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jdv.16065","article-title":"Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis","volume":"34","author":"Melchers","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.lpm.2022.104126_bib0027","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.semdp.2016.11.005","article-title":"A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders","volume":"34","author":"Kempf","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0028","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0029","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2022.104126_bib0030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/PAS.0000000000001449","article-title":"Clinical, histologic, and molecular characteristics of Anaplastic Lymphoma Kinase-positive primary cutaneous anaplastic large cell lymphoma","volume":"44","author":"Melchers","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0031","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0032","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0033","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2016-02-694455","article-title":"No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course","volume":"128","author":"Schrader","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0034","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2014-07-588434","article-title":"A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders","volume":"124","author":"Velusamy","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0035","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjd.13476","article-title":"Diagnostic and prognostic significance of CDKN2A\/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease","volume":"172","author":"Nicolae-Cristea","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0036","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12788\/j.sder.2018.015","article-title":"NK\/T-cell lymphoma, nasal type, \u03b3\u03b4 T-cell lymphoma, and CD8-positive epidermotropic T-cell lymphoma-clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Geller","year":"2018","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.lpm.2022.104126_bib0037","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.semdp.2016.11.003","article-title":"Cutaneous EBV-related lymphoproliferative disorders","volume":"34","author":"Gru","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0038","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0039","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2022.104126_bib0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PAS.0000000000000307","article-title":"Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: a conceptual and practical dilemma","volume":"39","author":"Bosisio","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0041","first-page":"1","article-title":"Subcutaneous panniculitis-like T-cell lymphoma, lupus erythematosus profundus, and overlapping cases: molecular characterization through the study of 208 genes","author":"Machan","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.lpm.2022.104126_bib0042","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2133.2008.08761.x","article-title":"The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality","volume":"159","author":"Massone","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0043","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/PAS.0b013e318275d1a2","article-title":"TCR-gamma expression in primary cutaneous T-cell lymphomas","volume":"37","author":"Rodriguez-Pinilla","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0044","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/PAS.0000000000000768","article-title":"Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (\u03b3\u03b4) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous \u03b3\u03b4 T-Cell Lymphomas","volume":"41","author":"Merrill","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0045","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T- cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0046","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous \u03b3\u03b4 T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0047","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0048","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/his.12371","article-title":"Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features","volume":"67","author":"Robson","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.lpm.2022.104126_bib0049","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/modpathol.2016.240","article-title":"Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas","volume":"30","author":"Guitart","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0050","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?","volume":"31","author":"Petrella","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0051","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cup.12045","article-title":"Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features","volume":"40","author":"Greenblatt","year":"2013","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0052","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/cup.13020","article-title":"Primary cutaneous acral CD8 positive T-cell lymphoma with extra-cutaneous involvement: A long-standing case with an unexpected progression","volume":"44","author":"Alberti-Violetti","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0053","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PAS.0b013e318230df87","article-title":"Expression of programmed death-1 in primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma","volume":"36","author":"Cetinozman","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0054","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium- sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodriguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0056","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO- EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2022.104126_bib0057","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaad.2013.04.047","article-title":"Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease- free survival in a series of 137 patients","volume":"69","author":"Servitje","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0058","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":"The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment","volume":"112","author":"van Maldegem","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0059","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.semdp.2016.11.007","article-title":"Cutaneous marginal zone lymphomas","volume":"34","author":"Swerdlow","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0061","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2022.104126_bib0062","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0063","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2014.01.862","article-title":"Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis","volume":"70","author":"Abdul-Wahab","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0064","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2022.104126_bib0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.2005.02.0842","article-title":"Array- based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma","volume":"24","author":"Dijkman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2022.104126_bib0066","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jid.2016.04.018","article-title":"MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma","volume":"136","author":"Menguy","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0067","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/PAS.0b013e3181e5060a","article-title":"IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma","volume":"34","author":"Koens","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0068","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/modpathol.2013.156","article-title":"Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma","volume":"27","author":"Pham-Ledard","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0069","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jid.2013.265","article-title":"Nuclear factor-kappaB pathway-activating gene aberrancies in primary cutaneous large B-cell lymphoma, leg type","volume":"134","author":"Koens","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0070","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","author":"Senff","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.lpm.2022.104126_bib0071","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2013a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0072","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/PAS.0000000000000225","article-title":"Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases","volume":"38","author":"Koens","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2022.104126_bib0073","first-page":"322","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida","year":"2007","journal-title":"J Rheumatol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498222000197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498222000197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:08:09Z","timestamp":1760105289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498222000197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0755498222000197"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2022.104126","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2022.104126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104126"}}